Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78% Market Closed
Market Cap: 161.4m CAD

Immunoprecise Antibodies Ltd
Investor Relations

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The company is headquartered in Vancouver, British Columbia and currently employs 73 full-time employees. The firm is focused on offering species-agnostic advancements, such as the B cell Select single-cell interrogation technology, DeepDisplay custom phage libraries, as well as the Abthena bispecific program. Its geographical segments include United States of America, Canada and Europe. The Company’s Antibody Discovery offers design, immunization, characterization and optimization, and preclinical services. The firm offers mammalian protein expression and purification services as stand-alone or in combination after an antibody discovery project to produce the number of antibodies that need for further work. Its mammalian rPEx platform allows the production of all kinds of proteins, including difficult-to-express proteins, Fc-fusion proteins and bispecific antibodies.

Show more
Loading
IPA
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2023
Call Date
Jul 7, 2023
Q4 2023 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls

Management

Dr. Jennifer Lynne Bath Ph.D.
CEO, Pres & Non-Independent Director
No Bio Available
Mr. Brad McConn
Chief Financial Officer
No Bio Available
Dr. Ilse Roodink
Chief Scientific Officer
No Bio Available
Mr. David E. Orton
Chief Operating Officer
No Bio Available
Ms. Carla Dahl
VP of Marketing
No Bio Available
Dr. Barry Neil Duplantis
VP of Client Relations
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
880 - 580 Hornby Street
Contacts
+16048060626.0
immunoprecise.com